WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLDX

Based on 6 analysts offering 12 month price targets for Celldex Therapeutics Inc

Min Forecast
$24.00+1.82%
Avg Forecast
$43.67+85.27%
Max Forecast
$62.00+163.05%

Should I buy or sell CLDX stock?

Based on 6 analysts offering ratings for Celldex Therapeutics Inc.

Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 16.67%
Although CLDX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CLDX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their CLDX stock forecasts and price targets.

CLDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-10-21
lockedlocked$00.00+00.00%2025-09-17
lockedlocked$00.00+00.00%2025-08-20
lockedlocked$00.00+00.00%2025-08-20
HC Wainwright & Co.
Bottom 11%
11
BuyMaintains$42.00+78.19%2025-08-20

1 of 1

Forecast return on equity

Is CLDX forecast to generate an efficient return?

Company
-17.98%
Industry
275.71%
Market
238.37%
CLDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLDX forecast to generate an efficient return on assets?

Company
-16.59%
Industry
114.68%
CLDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLDX earnings per share forecast

What is CLDX's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
-$4.52
Avg 2 year Forecast
-$4.88
Avg 3 year Forecast
-$4.25

CLDX revenue forecast

What is CLDX's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$3.2M+21.38%
Avg 2 year Forecast
$8.0M+207.92%
Avg 3 year Forecast
$162.9M+6,165.38%
CLDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLDX revenue growth forecast

How is CLDX forecast to perform vs Biotechnology companies and vs the US market?

Company
267.35%
Industry
119.45%
Market
23.3%
CLDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLDX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLDX$23.57$43.67+85.27%Buy
TYRA$29.19$42.29+44.86%Strong Buy
ORKA$32.64$53.56+64.08%Strong Buy
AMLX$14.07$22.00+56.36%Strong Buy
OCS$28.54$39.33+37.82%Strong Buy
View Top Biotech Stocks

Celldex Therapeutics Stock Forecast FAQ

Is Celldex Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: CLDX) stock is to Buy CLDX stock.

Out of 6 analysts, 3 (50%) are recommending CLDX as a Strong Buy, 2 (33.33%) are recommending CLDX as a Buy, 0 (0%) are recommending CLDX as a Hold, 0 (0%) are recommending CLDX as a Sell, and 1 (16.67%) are recommending CLDX as a Strong Sell.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.

What is CLDX's earnings growth forecast for 2026-2028?

(NASDAQ: CLDX) Celldex Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 61.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.85%.

Celldex Therapeutics's earnings in 2026 is -$224,532,000.On average, 15 Wall Street analysts forecast CLDX's earnings for 2026 to be -$300,099,101, with the lowest CLDX earnings forecast at -$318,439,155, and the highest CLDX earnings forecast at -$279,785,498. On average, 13 Wall Street analysts forecast CLDX's earnings for 2027 to be -$324,187,034, with the lowest CLDX earnings forecast at -$402,444,576, and the highest CLDX earnings forecast at -$230,247,417.

In 2028, CLDX is forecast to generate -$282,297,288 in earnings, with the lowest earnings forecast at -$341,231,323 and the highest earnings forecast at -$203,734,078.

What is CLDX's revenue growth forecast for 2026-2028?

(NASDAQ: CLDX) Celldex Therapeutics's forecast annual revenue growth rate of 267.35% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 119.45%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.3%.

Celldex Therapeutics's revenue in 2026 is $2,600,000.On average, 14 Wall Street analysts forecast CLDX's revenue for 2026 to be $209,714,530, with the lowest CLDX revenue forecast at $0, and the highest CLDX revenue forecast at $837,263,335. On average, 13 Wall Street analysts forecast CLDX's revenue for 2027 to be $531,994,465, with the lowest CLDX revenue forecast at $0, and the highest CLDX revenue forecast at $2,434,841,516.

In 2028, CLDX is forecast to generate $10,824,618,826 in revenue, with the lowest revenue forecast at $3,167,646,283 and the highest revenue forecast at $24,420,180,593.

What is CLDX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CLDX) forecast ROA is -16.59%, which is lower than the forecast US Biotechnology industry average of 114.68%.

What is CLDX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year CLDX price target, the average CLDX price target is $43.67, with the highest CLDX stock price forecast at $62.00 and the lowest CLDX stock price forecast at $24.00.

On average, Wall Street analysts predict that Celldex Therapeutics's share price could reach $43.67 by Dec 17, 2026. The average Celldex Therapeutics stock price prediction forecasts a potential upside of 85.27% from the current CLDX share price of $23.57.

What is CLDX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CLDX) Celldex Therapeutics's current Earnings Per Share (EPS) is -$3.38. On average, analysts forecast that CLDX's EPS will be -$4.52 for 2026, with the lowest EPS forecast at -$4.79, and the highest EPS forecast at -$4.21. On average, analysts forecast that CLDX's EPS will be -$4.88 for 2027, with the lowest EPS forecast at -$6.06, and the highest EPS forecast at -$3.47. In 2028, CLDX's EPS is forecast to hit -$4.25 (min: -$5.14, max: -$3.07).

What is CLDX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CLDX) forecast ROE is -17.98%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.